Compound ID | 481
WCK-771A
Class: Fluoroquinolone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | DNA synthesis inhibitor. DNA gyrase inhibitor |
| Target Pathogen: | Active against methicillin-resistant Staphylococcus aureus |
| Description: | Arginine salt of the tricyclic fluoroquinolone S-(−)-nadifloxacin |
| Institute where first reported: | Wockhardt, India |
| Year first mentioned: | 2001 |
| Highest development stage: | Phase 1 (NCT01875939 and NCT05640531 for WCK-771A) |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/349981768 |
| Guide to Pharmacology: | levonadifloxacin |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.